Mass spectrometry: from proteomics to metabolomics and lipidomics.

@article{Griffiths2009MassSF,
  title={Mass spectrometry: from proteomics to metabolomics and lipidomics.},
  author={W. Griffiths and Yuqin Wang},
  journal={Chemical Society reviews},
  year={2009},
  volume={38 7},
  pages={
          1882-96
        }
}
  • W. Griffiths, Yuqin Wang
  • Published 2009
  • Chemistry, Medicine
  • Chemical Society reviews
  • Mass spectrometry (MS) in combination with liquid chromatography (LC), i.e. LC-MS, is the key analytical technique on which the emerging "omics" technologies of proteomics, metabolomics and lipidomics are based. It provides both structural and quantitative data and can be used in a "global" or "targeted" manner allowing on the one hand the identification of thousands of proteins from a tissue, or on the other the detection of biologically active metabolites at levels of a few parts-per-billion… CONTINUE READING
    215 Citations
    On the future of “omics”: lipidomics
    • 29
    The Role of Mass Spectrometry in the “Omics” Era
    • 51
    • PDF
    Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    • 170
    • Highly Influenced
    • PDF
    Applications of mass spectrometry to lipids and membranes.
    • 149
    Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    • 40
    • Highly Influenced
    • PDF
    Overview of mass spectrometry-based metabolomics: opportunities and challenges.
    • 129
    Mass spectrometry based environmental metabolomics: a primer and review
    • 100
    Targeted metabolomics for biomarker discovery.
    • 205

    References

    SHOWING 1-10 OF 39 REFERENCES
    Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids.
    • W. Griffiths
    • Chemistry, Medicine
    • Mass spectrometry reviews
    • 2003
    • 228
    Mass spectrometry-based proteomics
    • 5,854
    • PDF
    Top-down lipidomic screens by multivariate analysis of high-resolution survey mass spectra.
    • 172
    • PDF
    The lipid maps initiative in lipidomics.
    • 109
    The Human Plasma Proteome
    • 3,030
    • PDF
    An update on lipidomics: progress and application in biomarker and drug development.
    • X. Han
    • Medicine
    • Current opinion in molecular therapeutics
    • 2007
    • 32